España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Seymour Asset Management
Cannabis Valuations 'More Mathematical, More Balance Sheet Driven' Than Before: Insights From Industry Experts
EXCLUSIVE: Find Value In Large Multinationals And Catch The Dividend Yield, Says Tim Seymour
EXCLUSIVE: The Metrics That Matter — Or How To Understand The Value Of Cannabis Companies
EXCLUSIVE: Find Value In Large Multinationals And Catch The Dividend Yield, Says Tim Seymour
EXCLUSIVE: The Metrics That Matter — Or How To Understand The Value Of Cannabis Companies
Why 280e Change Spells Good News For Cannabis Cash Flow: Jason Wild Weighs In
These Cannabis ETFs Fall Short Amidst S&P/TSX Discontinuation: What Investors Need To Know
Why 280e Change Spells Good News For Cannabis Cash Flow: Jason Wild Weighs In
These Cannabis ETFs Fall Short Amidst S&P/TSX Discontinuation: What Investors Need To Know
'The Only Thing We Can Do As An Industry Is Learn,' Says Emily Paxhia On Navigating The Cannabis Investment Landscape
CNBC's Tim Seymour Says Cannabis Investors May Find Positive Catalysts In Unexpected Places
Read More...
Seymour Asset Management Recent News
Meta Platforms, This Biotech ETF And These China Plays Are CNBC's 'Final Trades'
The iShares Biotechnology ETF (NASDAQ: IBB), which includes several large cap biotechs, has recently narrowed its year-to-date loss to aroun
Tim Seymour Guests On Benzinga's PreMarket Prep: 'We've Priced In An Enormous Amount Of Recession'
Tim Seymour is the founder and Chief Investment Officer of Seymour Asset Management. It aims to provide clients with asset management and wealth management services, including direct investment and allocation to private equity and alternative assets.
Investors Talk Cannabis After COVID-19: What Will 'The New Normal' Look Like?
Cannabis investors and experts came together Monday to discuss the effects of the COVID-19 pandemic on the industry at the Virtual Benzinga Cannabis Capital Conference.
It's A Buyer's Market In Cannabis Stocks, But The Game Has Changed Dramatically
Tim Seymour Compares Aurora Cannabis And Canopy Growth, Sees Path To Profitability
4 Pro Cannabis Investors Talk Stocks
Spruce Point, Kerrisdale Talk Bearish Bets: 'You Have To Work Harder To Understand The Short'
4 Pro Takes On How To Pick Cannabis Investments
A Cannabis Bubble? Tim Seymour Believes Market Has Been 'Grossly Understated'
Tim Seymour Talks Emerging Markets, Cannabis Stocks On PreMarket Prep